News
BLACR
0.2300
0.00%
0.00
OSR Holdings inks VXM01 global license deal with BCM Europe worth up to $815 million
PUBT · 2h ago
OSR Holdings appoints Yeiseok Kim as chief operating officer effective April 16
PUBT · 6d ago
OSR Holdings COO Yeiseok Kim files initial beneficial ownership statement
PUBT · 04/16 14:10
OSR Holdings issues $1.06 million convertible note to retire $2.02 million warrants
Reuters · 04/09 13:16
OSR Holdings amends 8-K, corrects VXM01 license agreement exhibit share price
Reuters · 04/03 10:15
OSR HOLDINGS INC - TO PROVIDE VAXIMM WITH UP TO $30 MLN DEVELOPMENT FINANCING FACILITY - SEC FILING
Reuters · 04/02 19:48
OSR Holdings signs term sheet for VXM01 license with up to $815 million milestones
Reuters · 04/02 19:46
OSR Holdings FY25 operating loss widens 57% to $18.3 million; net sales fall 18% to $2.9 million
Reuters · 03/31 20:12
Emerging Growth Research reaffirms OSR Holdings Buy-Emerging, keeps $10 price target
Reuters · 03/30 13:24
OSR Holdings to present investor update at Emerging Growth Conference
Reuters · 03/30 13:04
OSR Holdings updates VXM01 licensing deal structure with up to USD 815 million in milestones
Reuters · 03/23 12:38
OSR subsidiary Woori IO signs NDA with Sinopharm to explore China opportunities
Reuters · 03/19 12:55
OSR HOLDINGS INC - IN PRELIMINARY DISCUSSIONS FOR ACQUISITION OF 16% CONTROLLING STAKE IN SILLAJEN - SEC FILING
Reuters · 03/16 12:22
Nasdaq Grants OSR Holdings 180-Day Extension to Meet $1 Minimum Bid Rule
Reuters · 03/05 14:30
OSR Holdings Advances Toward VXM01 Licensing Deal With BCM Europe AG
Reuters · 02/02 14:50
OSR Holdings Closes Woori IO Acquisition
Reuters · 01/27 14:52
OSR HOLDINGS INC: EVALUATING WHETHER A COMBINED PLATFORM COULD SUPPORT A STANDALONE IPO IN KOREA
Reuters · 01/27 14:30
Woori IO Accelerates Launch of Noninvasive Glucose Wearables Under OSR Holdings
Reuters · 01/22 14:56
Vaximm Appoints Sébastien Wieckowski as Chief Scientific Officer
Reuters · 01/16 14:21
BRIEF-Osr Holdings Inc - Vaximm AG Enters Binding Term Sheet With Bcm Europe AG - SEC Filing
Reuters · 01/14 14:28
More
Webull provides a variety of real-time BLACR stock news. You can receive the latest news about Bellevue Life Sciences Acquisition Rights Exp 9 Feb 2028 through multiple platforms. This information may help you make smarter investment decisions.
About BLACR
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.